Concourse Financial Group Securities, Inc. Genmab A/S Transaction History

Concourse Financial Group Securities, Inc.

$0
Q2 2025

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

100.0%

Previous 100.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$17.98 - $23.09 $0 - $0	0 New	0 $0
Q1 2025 May 14, 2025	SELL	$18.69 - $24.14 $7,289 - $9,414	-390 Closed	0 $0
Q4 2024 Feb 13, 2025	BUY	$20.02 - $24.15 $40 - $48	2 Added 0.52%	390 $8,000
Q3 2024 Oct 10, 2024	SELL	$23.84 - $28.48 $2,765 - $3,303	-116 Reduced 23.02%	388 $9,000
Q2 2024 Jul 23, 2024	BUY	$25.13 - $30.27 $1,331 - $1,604	53 Added 11.75%	504 $12,000
Q1 2024 Apr 30, 2024	SELL	$26.43 - $32.77 $1,057 - $1,310	-40 Reduced 8.15%	451 $13,000
Q4 2023 Feb 07, 2024	SELL	$27.94 - $35.44 $2,179 - $2,764	-78 Reduced 13.71%	491 $15,000
Q3 2023 Oct 25, 2023	BUY	$35.27 - $42.24 $16,294 - $19,514	462 Added 431.78%	569 $20,000
Q2 2023 Aug 10, 2023	BUY	$37.4 - $42.94 $785 - $901	21 Added 24.42%	107 $4,000
Q1 2023 May 15, 2023	SELL	$34.88 - $43.22 $837 - $1,037	-24 Reduced 21.82%	86 $3,000
Q3 2022 Nov 15, 2022	SELL	$31.52 - $373.61 $1,103 - $13,076	-35 Reduced 24.14%	110 $4,000
Q2 2022 Aug 09, 2022	BUY	$26.83 - $38.57 $2,307 - $3,317	86 Added 145.76%	145 $5,000
Q4 2021 Feb 07, 2022	BUY	$35.87 - $47.12 $753 - $989	21 Added 55.26%	59 $2,000
Q4 2020 Feb 02, 2021	SELL	$33.66 - $40.76 $1,750 - $2,119	-52 Reduced 57.78%	38 $2,000
Q3 2020 Nov 13, 2020	BUY	$33.07 - $38.68 $595 - $696	18 Added 25.0%	90 $3,000
Q2 2020 Aug 13, 2020	SELL	$20.05 - $33.89 $340 - $576	-17 Reduced 19.1%	72 $2,000
Q1 2020 May 13, 2020	SELL	$17.15 - $25.22 $3,344 - $4,917	-195 Reduced 68.66%	89 $2,000
Q3 2019 Nov 13, 2019	BUY	$18.0 - $21.38 $5,112 - $6,071	284 New	284 $6,000

Others Institutions Holding GMAB

# of Institutions

258

Shares Held

65M

Call Options Held

32.5K

Put Options Held

55K

Alliancebernstein L.P. New York, NY

10.7M
Shares

$322 Million
0.08% of portfolio
Orbis Allan Gray LTD Hamilton, D0

7.92M
Shares

$240 Million
1.07% of portfolio
Black Rock Inc. New York, NY

5.08M
Shares

$154 Million
0.0% of portfolio
Arrowstreet Capital, Limited Partnership Boston, MA

3.64M
Shares

$110 Million
0.08% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

3.57M
Shares

$108 Million
0.01% of portfolio

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $19.9B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account